NEWS & INSIGHTS

A new attention-grabbing PHE study, commissioned by the Alzheimer’s Association, investigates the potential savings of obtaining an earlier diagnosis. (more…)

Jason Shafrin, senior director at Precision Health Economics, shares his initial thoughts on the merger of Cigna and Express Scripts with NBCNews. (more…)

Jeremy Schafer, senior vice president, director, Payer Access Solutions, discusses UnitedHealthcare’s recent announcement to apply rebates at point of sale for its fully insured commercial members. (more…)

Ami Gopalan, vice president, Payer Access Solutions with Precision for Value, discusses copay accumulator programs and their impact on patient deductibles and out-of-pocket costs. (more…)

With many manufacturers experimenting with outcomes-based pricing, Jeremy Schafer, senior vice president, director, Payer Access Solutions, offers his expertise on whether this approach should become standard for all specialty drug launches. (more…)

Dan Renick is a featured expert on drug pricing and defining value as a source for the Med Ad News Special Feature, “The Value Equation.” (more…)

Andrew Cournoyer, vice president at Precision for Value, offers an initial reaction to CMS’s new flexibility on offering benefits and controlling costs, which are expected to grow the Medicare Advantage program. (more…)

Precision for Value’s Jeremy Schafer is featured in Managed Healthcare Executive, offering expert insight on how rebates contribute to patient savings as well as greater transparency among stakeholders. (more…)

Precision Value & Health president Dan Renick speaks with American Healthcare Leader on the evolution of the healthcare industry and the challenges manufacturers face today. (more…)

Jeremy Schafer, director of Precision’s Payer Access Solutions, details the challenges facing gene therapy reimbursement and offers potential solutions. (more…)